8 research outputs found

    Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation

    No full text
    <div><p>Diabetic cardiomyopathy is a specific disease process distinct from coronary artery disease and hypertension. The disease features cardiac remodeling stimulated by hyperglycemia of the left ventricle wall and disrupts contractile functions. Cardiac mast cells may be activated by metabolic byproducts resulted from hyperglycermia and then participate in the remodeling process by releasing a multitude of cytokines and bioactive enzymes. Nedocromil, a pharmacologic stabilizer of mast cells, has been shown to normalize cytokine levels and attenuate cardiac remodeling. In this study, we describe the activation of cardiac mast cells by inducing diabetes in normal mice using streptozotocin (STZ). Next, we treated the diabetic mice with nedocromil for 12 weeks and then examined their hearts for signs of cardiac remodeling and quantified contractile function. We observed significantly impaired heart function in diabetic mice, as well as increased cardiac mast cell density and elevated mast cell secretions that correlated with gene expression and aberrant cytokine levels associated with cardiac remodeling. Nedocromil treatment halted contractile dysfunction in diabetic mice and reduced cardiac mast cell density, which correlated with reduced bioactive enzyme secretions, reduced expression of extracellular matrix remodeling factors and collagen synthesis, and normalized cytokine levels. However, the results showed nedocromil treatments did not return diabetic mice to a normal state. We concluded that manipulation of cardiac mast cell function is sufficient to attenuate cardiomyopathy stimulated by diabetes, but other cellular pathways also contribute to the disease process.</p> </div

    Characterization of cardiac mast cell activation in normal or STZ-induced diabetic mice after nedocromil (Ned) treatments.

    No full text
    <p>(A) Quantification of chymase-positive mast cells. Chymase-positive cells from immunohistochemically stained cardiac tissues were counted in 100 random fields at 400X magnification. (B) Mast cell density in sample tissues was determined by dividing the number of chymase-positive cells by the total number of cells in the visual fields. (C) mRNA expression levels of chymase in sample tissues were normalized to GAPDH expression and depicted as fold-change relative to the untreated normal group. (D) Representative results of protein expression analysis for chymase, tryptase, and histamine in sample tissues using western blot. GAPDH expression is shown as loading control. Quantitative data are displayed as means ± SD (n = 15 per group). <sup>*</sup>P<0.05 vs. untreated normal group; <sup>#</sup>P<0.05 vs. untreated diabetic group.</p

    Cardiac function of isolated and perfused hearts from normal and STZ-induced diabetic mice after nedocromil (Ned) treatments.

    No full text
    <p>Contractile function of the heart was determined using a multi-channel physiological recorder. Changes in heart work (A), heart rate (B), maximal rate of contraction (C), and relaxation (D) are presented. Quantitative data are shown as means ± SD (n = 15 per group). *P<0.05 vs. untreated normal group; <sup>#</sup>P<0.05 vs. untreated diabetic group.</p

    Collagen deposits in the left ventricle (LV) of normal and STZ-induced diabetic mice after nedocromil (Ned) treatments.

    No full text
    <p>(A) Representative images of LV sections stained with Masson's trichrome at 100X magnification. Blue color indicates collagen deposits. (B) Quantification of LV collagen volume fraction (CVF). CVF is represented as the ratio of collagen area/total area. (C) The mRNA expression levels of type I and type III collagen are normalized to GAPDH expression and depicted as fold-change relative to the untreated normal group. (D) Representative results of protein expression analysis for collagen I, collagen III, MMP-2, and MMP-9 in sample tissues using western blot. GAPDH expression is shown as loading control and used for normalization. (E) Quantification of type I and type III collagen, MMP-2, and MMP-9 protein levels normalized to GAPDH. Quantitative data are displayed as means ± SD (n = 15 per group). <sup>*</sup>P<0.05 vs. untreated normal group; <sup>#</sup>P<0.05 vs. untreated diabetic group.</p

    The blood glucose level and body weight of normal and STZ-induced diabetic mice were monitored for 12 weeks after nedocromil (Ned) treatment, as described in Methods.

    No full text
    <p>(A) The blood glucose levels of the different treatment groups at the indicated time points. (B) The body weights of the different treatment groups at the indicated time points. (n = 15 per group).</p

    ELISA assay for cytokine expression in cardiac tissues of normal and STZ-induced diabetic mice treated with nedocromil (Ned) or controls.

    No full text
    <p>The graphs show the quantitative levels of (A) TNF-α, (B) IFN-γ, (C) IL-4, (D) IL-10, and (E) Angiotensin II (Ang II) of the indicated sample groups. Quantitative data are displayed as means ± SD (n = 15 per group). <sup>*</sup>P<0.05 vs. untreated normal group; <sup>#</sup>P<0.05 vs. untreated diabetic group.</p

    Cellulose Fiber-Based Hierarchical Porous Bismuth Telluride for High-Performance Flexible and Tailorable Thermoelectrics

    No full text
    Porous modification is a general approach to endowing the rigid inorganic thermoelectric (TE) materials with considerable flexibility, however, by which the TE performances are severely sacrificed. Thus, there remains an ongoing struggle against the trade-off between TE properties and flexibility. Herein, we develop a novel strategy to combine Bi<sub>2</sub>Te<sub>3</sub> thick film with ubiquitous cellulose fibers (CFs) via an unbalanced magnetron sputtering technique. Owing to the nano-micro hierarchical porous structures and the excellent resistance to crack propagation of the Bi<sub>2</sub>Te<sub>3</sub>/CF architectures, the obtained sample with a nominal Bi<sub>2</sub>Te<sub>3</sub> deposition thickness of tens of micrometers exhibits excellent mechanically reliable flexibility, of which the bending deformation radius could be as small as a few millimeters. Furthermore, the Bi<sub>2</sub>Te<sub>3</sub>/CF with rational internal resistance and tailorable shapes and dimensions are successfully fabricated for practical use in TE devices. Enhanced Seebeck coefficients are observed in the Bi<sub>2</sub>Te<sub>3</sub>/CF as compared to the dense Bi<sub>2</sub>Te<sub>3</sub> films, and the lattice thermal conductivity is remarkably reduced due to the strong phonon scattering effect. As a result, the TE figure of merit, <i>ZT</i>, is achieved as high as ∼0.38 at 473 K, which competes with the best flexible TEs and can be further improved by optimizing the carrier concentrations. We believe this developed technique not only opens up a new window to engineer flexible TE materials for practical applications but also promotes the robust development of the fields, such as paper-based flexible electronics and thin-film electronics
    corecore